Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics | $6.17 | -$7.50 | -54.86% | 4.1M | $99M | $5.01$19.15 |
| LYRA | Lyra Therapeutics | $2.07 | -$1.70 | -45.05% | 1.3M | $6.7M | $1.63$37.50 |
| LXEO | Lexeo Therapeutics | $8.10 | -$2.44 | -23.15% | 4.5M | $769M | $1.45$10.99 |
| ATEC | Alphatec | $17.97 | -$4.68 | -20.66% | 347.7K | $3.4B | $8.81$23.29 |
| DGNX | Diginex | $2.45 | -$0.63 | -20.45% | 2.2M | $622M | $0.45$39.85 |
| CLNN | Clene | $5.17 | -$1.23 | -19.16% | 309.3K | $66M | $2.28$13.50 |
| SEV | Aptera Motors | $4.01 | -$0.89 | -18.10% | 341.2K | $135M | $3.55$40.85 |
| ANF | Abercrombie & Fitch | $102.32 | -$22.55 | -18.06% | 338.2K | $5.7B | $65.40$147.91 |
| OESX | Orion Energy Systems | $14.00 | -$3.00 | -17.65% | 75.7K | $60M | $5.50$18.63 |
| NUVB | Nuvation Bio | $6.68 | -$1.37 | -16.98% | 12.1M | $2.8B | $1.54$9.75 |
Related Articles
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
Cory Renauer|Oct 29, 2024
It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.
Is Abercrombie & Fitch's Pullback a Buying Opportunity?
Leo Sun|Sep 1, 2024
The apparel retailer's turnaround story isn't over yet.
Advertisement
Mall Retailers Are Alive and Well
Motley Fool Staff|Jun 7, 2024
Abercrombie & Fitch and Dick's Sporting Goods show that familiar names near the food court are doing just fine.
Peloton's Woes and Abercrombie & Fitch's Latest Resurgence
Motley Fool Staff|Sep 3, 2023
Abercrombie is back in vogue, but be careful chasing this cyclical business.
2 Retail Stocks Leading Markets Higher Wednesday
Dan Caplinger|Aug 23, 2023
Forget what you've heard about consumer weakness, at least with these companies.
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
George Budwell, PhD|Aug 16, 2023
This small-cap biotech might be a hidden gem.
Missed Out On Intuitive Surgical's Boom? This Stock May Be a Better Buy Now
James Halley|Jun 6, 2023
Alphatec's strong revenue growth makes it worth watching.
Abercrombie & Fitch Stock: Buy, Sell, or Hold?
Leo Sun|May 26, 2023
The apparel retailer seems to have turned a corner.
2 Best Growth Stocks to Buy in April
George Budwell, PhD|Apr 3, 2023
Takeover interest is spurring these two biotech stocks higher.
